# A Study to Evaluate the Effectiveness and Safety of Multiple Doses of Tapentadol(CG5503) in Patients Awaiting Joint Replacement Surgery

> **NCT00361582** · PHASE3 · COMPLETED · sponsor: **Johnson & Johnson Pharmaceutical Research & Development, L.L.C.** · enrollment: 669 (actual)

## Conditions studied

- Osteoarthritis
- Pain Assessment
- Arthralgia

## Interventions

- **DRUG:** CG5503 IR; tapentadol

## Key facts

- **NCT ID:** NCT00361582
- **Lead sponsor:** Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-10
- **Primary completion:** 2007-08
- **Final completion:** 2007-08
- **Target enrollment:** 669 (ACTUAL)
- **Last updated:** 2011-06-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00361582

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00361582, "A Study to Evaluate the Effectiveness and Safety of Multiple Doses of Tapentadol(CG5503) in Patients Awaiting Joint Replacement Surgery". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT00361582. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*